Pioneering a Solution for Canine Muscle Atrophy with Ursolic Acid
02/20/2025

2:30PM EST/1:30PM CST/12:30PM MST/11:30AM PST
Muscle atrophy often occurs as part of the normal aging process as well as with many chronic disease processes and sometimes post surgically in our canine patients. During this program, we will discuss the pathophysiology of canine muscle atrophy in sarcopenic and cachectic patients and the resultant negative effects on muscle health and mobility. We will review diagnostic tools used for assessing muscle health as well as current therapeutic approaches. Ursolic acid will be introduced as a solution for improving muscle strength, function and overall mobility. We will review the discovery of ursolic acid and supporting scientific efficacy data in mice, humans and canines.
This program is pending approval for 0.5 hour of continuing education credit in jurisdictions that recognize RACE approval. Virbac is NYSED approved as a New York State sponsor of continuing education for veterinarians and veterinary technicians.
*You must attend the full presentation to receive CE Credit.
Dr. Michelle Rosentel is a Technical Services Veterinarian with Virbac. She has a background in small animal clinical practice with teaching experience. Dr. Rosentel is proud to provide education for veterinarians and represent Virbac on the Field Veterinary Team.